Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients. [electronic resource] by
- Frattini, M
- Saletti, P
- Romagnani, E
- Martin, V
- Molinari, F
- Ghisletta, M
- Camponovo, A
- Etienne, L L
- Cavalli, F
- Mazzucchelli, L
Producer: 20071214
In:
British journal of cancer vol. 97
Availability: No items available.
|
|
|
20.
|
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. [electronic resource] by
- Molinari, F
- Martin, V
- Saletti, P
- De Dosso, S
- Spitale, A
- Camponovo, A
- Bordoni, A
- Crippa, S
- Mazzucchelli, L
- Frattini, M
Producer: 20090424
In:
British journal of cancer vol. 100
Availability: No items available.
|